Forte Biosciences, Inc. - Common Stock, par value $0.001 per share (FBRX)
CUSIP: 34962G109
Q4 2023 13F Holders as of 31 Dec 2023
- Type / Class
- Equity / Common Stock, par value $0.001 per share
- Shares outstanding
- 20,563,488
- Total 13F shares
- 18,862,822
- Share change
- +128,516
- Total reported value
- $15,499,549
- Put/Call ratio
- 1.7%
- Price per share
- $0.82
- Number of holders
- 34
- Value change
- +$107,364
- Number of buys
- 8
- Number of sells
- 7
Quarterly Holders Quick Answers
What is CUSIP 34962G109?
CUSIP 34962G109 identifies FBRX - Forte Biosciences, Inc. - Common Stock, par value $0.001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 34962G109:
Top shareholders of FBRX - Forte Biosciences, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD |
13F
|
Company |
18%
|
3,624,548
|
$2,399,451 | — | 30 Sep 2023 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
16%
|
3,265,359
|
$2,161,667 | — | 30 Sep 2023 | |
| BVF INC/IL |
13F
|
Company |
15%
|
2,982,105
|
$1,974,154 | — | 30 Sep 2023 | |
| FRED ALGER MANAGEMENT, LLC |
13F
|
Company |
8.9%
|
1,838,965
|
$1,217,395 | — | 30 Sep 2023 | |
| FARALLON CAPITAL MANAGEMENT LLC |
13F
|
Company |
8.8%
|
1,810,455
|
$1,198,521 | — | 30 Sep 2023 | |
| BML Capital Management, LLC |
13F
|
Company |
8.6%
|
1,761,702
|
$1,166,247 | — | 30 Sep 2023 | |
| VANGUARD GROUP INC |
13F
|
Company |
3.2%
|
664,830
|
$440,117 | — | 30 Sep 2023 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1%
|
208,383
|
$138,009 | — | 30 Sep 2023 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.89%
|
182,164
|
$120,592 | — | 30 Sep 2023 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.62%
|
126,900
|
$84,000 | — | 30 Sep 2023 | |
| STATE STREET CORP |
13F
|
Company |
0.2%
|
41,664
|
$27,582 | — | 30 Sep 2023 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.2%
|
41,364
|
$27,383 | — | 30 Sep 2023 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.16%
|
33,756
|
$22,346 | — | 30 Sep 2023 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.13%
|
26,991
|
$17,868 | — | 30 Sep 2023 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.13%
|
26,911
|
$17,815 | — | 30 Sep 2023 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0.08%
|
15,827
|
$10,477 | — | 30 Sep 2023 | |
| Aries Wealth Management |
13F
|
Company |
0.06%
|
13,000
|
$7,540 | — | 30 Sep 2023 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.05%
|
10,763
|
$7,125 | — | 30 Sep 2023 | |
| HSBC HOLDINGS PLC |
13F
|
Company |
0.05%
|
10,745
|
$6,970 | — | 30 Sep 2023 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.02%
|
3,181
|
$2,106 | — | 30 Sep 2023 | |
| Cutler Group LLC / CA |
13F
|
Company |
0.02%
|
3,987
|
$2,000 | — | 30 Sep 2023 | |
| UBS Group AG |
13F
|
Company |
0.01%
|
2,471
|
$1,636 | — | 30 Sep 2023 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0.01%
|
1,080
|
$714 | — | 30 Sep 2023 | |
| MORGAN STANLEY |
13F
|
Company |
0%
|
994
|
$658 | — | 30 Sep 2023 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
647
|
$428 | — | 30 Sep 2023 | |
| Russell Investments Group, Ltd. |
13F
|
Company |
0%
|
453
|
$299 | — | 30 Sep 2023 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
235
|
$156 | — | 30 Sep 2023 | |
| LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA |
13F
|
Company |
0%
|
193
|
$92 | — | 30 Sep 2023 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
17
|
$11 | — | 30 Sep 2023 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0%
|
3
|
$2 | — | 30 Sep 2023 | |
| Patricia S. Walker |
3/4/5
|
Director |
—
class O/S missing
|
25,000
|
— | — | 01 Jun 2022 |
Institutional Holders of Forte Biosciences, Inc. - Common Stock, par value $0.001 per share (FBRX) as of Q4 2023
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2023 vs Q3 2023 Across Filers
| Investor | Q3 2023 Shares | Q4 2023 Shares | Share Diff | Share Chg % | Q3 2023 Value $ | Q4 2023 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
An asterisk sign (*) next to the price indicates that the price is likely invalid.